Kannan Vishwanath Latvia

  The VI International Economic Forum, set to take place from September 21 to 23, 2023, in the picturesque city of Riga, Latvia, promises to be a pivotal event for global economic discussions. With a distinguished lineup of speakers and experts, the forum aims to shed light on pressing contemporary issues. One such luminary is Dr. Kannan Vishwanath , a renowned figure in global opinion-making and an acclaimed speaker at various international forums. His talk on "Now is the Time for Open Innovation" will undoubtedly be a highlight of the event. Dr. Kannan's remarkable journey spans over 24 years of professional experience in the fields of Pharmaceutical and International Trade. His expertise extends to areas like Licensing, Business Development, API, Generics, and Finished Doses. His significant contributions have not gone unnoticed, as he has been honored with several prestigious awards. These include The Albert Schweitzer Medal for Science, The Malcolm Adiseshiah Award f...

Kannan K Vishwanath , a prominent figure in the field of international business and pharmaceuticals, recently delivered a captivating speech at the Pharma Summit & Awards 2021 organized by the esteemed Latvian Academy of Sciences. With an audience of distinguished industry veterans, his address shed valuable light on the profound impact of the COVID-19 pandemic on global business, particularly within the pharmaceutical sector. Dr. Vishwanath's insights focused on the crucial role of pharmaceutical products and vaccines in shaping human well-being, emphasizing the opportunities they present amidst the challenges posed by the pandemic. During his speech, Dr. Vishwanath also delved into the evolving dynamics of business accountability, drawing inspiration from the teachings of the renowned economist Milton Friedman from over half a century ago. By providing a historical perspective on corporate responsibility, he offered a thought-provoking analysis of how businesses can navigate ...

      The pharmaceutical industry has experienced a slowdown in growth in recent years due to current medicines reaching saturation levels in many markets. This has emphasized the need for the industry to invest in new drug development and gain a better understanding of the reasons behind falling drug sales, especially in emerging markets. To move forward successfully, it is essential for the industry to identify the market potential for new drugs and pinpoint the factors affecting sales. To achieve this, the pharmaceutical industry must adopt a 'big picture' or horizontal approach. This means looking beyond individual components and considering the broader landscape. By taking this approach, the industry can develop a comprehensive understanding of the various factors that impact drug sales, both internally and externally. The healthcare industry is shifting towards a patient-centric care model, recognizing the importance of meeting patient needs and preferences. However...

                    The pharmaceutical industry has experienced a slowdown in growth in recent years due to the saturation of existing medicines in the market. To address this challenge, the industry must invest in new drug development while also understanding and counteracting the decline in drug sales in emerging markets. This requires identifying the market potential for new drugs and determining the factors influencing declining sales. Taking a 'big picture' or horizontal approach is essential for the industry to move forward successfully. By considering the broader context and interconnections between various aspects of drug development and sales, pharmaceutical companies can make informed decisions and develop comprehensive strategies. The healthcare industry is shifting towards a patient-centric care model, but the pharmaceutical customer base is diverse, including hospital managers, doctors, pharmacists, patients, and caregivers....